Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 9/20 | 0.47 |
| ▸ | CTSB | P07858 | 5/20 | 0.47 |
| ▸ | CTSK | P43235 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 2/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | PREP | P48147 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7693965 | 0.91 | CAPN1 (0.46) | CAPN1CTSBCTSKCYP1A2CYP2C19 | |
| SCHEMBL7696167 | 0.86 | CAPN1 (0.57) | CAPN1CTSBCTSKCTSSCTSL | |
| SCHEMBL7696533 | 0.85 | CAPN1 (0.48) | CAPN1CTSBCTSKCTSSCTSL | |
| SCHEMBL7695268 | 0.84 | CTSB (0.44) | CAPN1CTSBCTSKCTSS | |
| SCHEMBL7696690 | 0.81 | CAPN1 (0.54) | CAPN1CTSBCTSKCTSSCTSL | |
| SCHEMBL7376391 | 0.80 | CAPN1 (0.49) | CAPN1CTSBCTSKCTSL | |
| SCHEMBL7689896 | 0.80 | CAPN1 (0.75) | CAPN1CTSBCTSKCTSSCTSL | |
| SCHEMBL7696610 | 0.79 | CAPN1 (0.58) | CAPN1CTSBCTSKCYP1A2CTSS | |
| SCHEMBL7690894 | 0.79 | CAPN1 (0.58) | CAPN1CTSBCTSKCYP1A2CTSS | |
| Hydrochloric Acid SCHEMBL7789980 | 0.79 | CAPN1 (0.48) | CAPN1CTSBCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |